[Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products].
D000328:Adult; D000863:Antacids / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy; D004384:Duodenoscopy; D004415:Dyspepsia / Q000188:drug therapy; D004942:Esophagitis, Peptic / Q000175:diagnosis / Q000188:drug therapy; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000188:drug therapy; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D013276:Stomach Ulcer / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors
D000863:Antacids; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists